Last update 31 May 2025

Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Paracetamol/fexofenadine/phenylephrine, EF 175, EF-175
+ [1]
Target
ADRA1 x COXs x H1 receptor
Action
agonists, inhibitors, antagonists
Mechanism
ADRA1 agonists(Adrenergic receptor alpha-1 agonists), COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Common ColdInfluenza, Human
Inactive Indication-
Originator Organization
Eurofarma Laboratórios SAEurofarma Laboratórios SA
Active Organization
Eurofarma Laboratórios SAEurofarma Laboratórios SA
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC9H14ClNO2
InChIKeyOCYSGIYOVXAGKQ-FVGYRXGTSA-N
CAS Registry61-76-7
View All Structures (3)

Related

1
Clinical Trials associated with Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride
NCT05118672
/ RecruitingPhase 3
A Multicenter, Randomized, Parallel-group, Double-blind, Comparative Trial of the Superiority of Paracetamol 500mg/Fexofenadine 60mg/Phenylephrine 20mg Fixed-dose Combination Versus Placebo in the Symptomatic Treatment of Flu and Cold
100 Clinical Results associated with Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride
Login to view more data
100 Translational Medicine associated with Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride
Login to view more data
100 Deals associated with Acetaminophen/Fexofenadine Hydrochloride/Phenylephrine Hydrochloride
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Common ColdPhase 3
Brazil
Eurofarma Laboratórios SAEurofarma Laboratórios SA
26 Mar 2025
Influenza, HumanPhase 3
Brazil
Eurofarma Laboratórios SAEurofarma Laboratórios SA
26 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free